Academic Journal

Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy

التفاصيل البيبلوغرافية
العنوان: Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy
المؤلفون: Zheng, Yang, van den Kerkhof, Magali, van der Meer, Tiffany, Gul, Sheraz, Kuzikov, Maria, Ellinger, Bernhard, de Esch, Iwan J.P., Siderius, Marco, Matheeussen, An, Maes, Louis, Sterk, Geert Jan, Caljon, Guy, Leurs, Rob
المصدر: Zheng , Y , van den Kerkhof , M , van der Meer , T , Gul , S , Kuzikov , M , Ellinger , B , de Esch , I J P , Siderius , M , Matheeussen , A , Maes , L , Sterk , G J , Caljon , G & Leurs , R 2023 , ' Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy ' , Journal of medicinal chemistry , vol. 66 , no. 15 , pp. 10252–10264 . https://doi.org/10.1021/acs.jmedchem.3c00161
سنة النشر: 2023
الوصف: Human African Trypanosomiasis (HAT), caused by Trypanosoma brucei, is one of the neglected tropical diseases with a continuing need for new medication. We here describe the discovery of 5-phenylpyrazolopyrimidinone analogs as a novel series of phenotypic antitrypanosomal agents. The most potent compound, 30 (NPD-2975), has an in vitro IC 50 of 70 nM against T. b. brucei with no apparent toxicity against human MRC-5 lung fibroblasts. Showing good physicochemical properties, low toxicity potential, acceptable metabolic stability, and other pharmacokinetic features, 30 was further evaluated in an acute mouse model of T. b. brucei infection. After oral dosing at 50 mg/kg twice per day for five consecutive days, all infected mice were cured. Given its good drug-like properties and high in vivo antitrypanosomal potential, the 5-phenylpyrazolopyrimidinone analog 30 represents a promising lead for future drug development to treat HAT.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1021/acs.jmedchem.3c00161
الاتاحة: https://research.vu.nl/en/publications/2a60ef90-35f6-488c-82ca-cc6d99e82799
https://doi.org/10.1021/acs.jmedchem.3c00161
https://hdl.handle.net/1871.1/2a60ef90-35f6-488c-82ca-cc6d99e82799
http://www.scopus.com/inward/record.url?scp=85166428037&partnerID=8YFLogxK
http://www.scopus.com/inward/citedby.url?scp=85166428037&partnerID=8YFLogxK
Rights: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.F8DAEC5
قاعدة البيانات: BASE
الوصف
DOI:10.1021/acs.jmedchem.3c00161